Product Information
QUETIAPINE 150 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.2018 per EA under NDC 16571080901. Its NADAC has been published 158 times since Jun 21, 2023.
Strength
150 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571080901
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA091388On Market Since
3/27/2012
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE 150 MG TABLET has been published 158 times since Jun 21, 2023, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2018 per EA |
|---|---|
| All-time high | $1.2809 (Mar 11, 2026) |
| All-time low | $0.9540 (Nov 20, 2024) |
| 52-week high | $1.2809 |
| 52-week low | $1.1998 |
| Median price | $1.1667 |
| Average price | $1.1723 |
| Largest weekly change | -14.6% (Nov 20, 2024) |
| Weeks tracked | 158 |
| Tracking since | Jun 21, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Quetiapine Fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of QUETIAPINE 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE 150 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $1.2018 per EA (NDC 16571080901), effective Jun 24, 2026.
How has the price of QUETIAPINE 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE 150 MG TABLET has risen 3.0%. It has been tracked across 158 weekly CMS publications since Jun 21, 2023.
What are the highest and lowest recorded NADAC prices for QUETIAPINE 150 MG TABLET?
Since Jun 21, 2023, the NADAC for QUETIAPINE 150 MG TABLET has ranged from a low of $0.9540 (Nov 20, 2024) to a high of $1.2809 (Mar 11, 2026), with a median of $1.1667 per EA.
Are there cheaper alternatives to QUETIAPINE 150 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QUETIAPINE 150 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures QUETIAPINE 150 MG TABLET?
QUETIAPINE 150 MG TABLET (NDC 16571080901) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification